Commit To Buy Celldex Therapeutics At $3, Earn 30% Using Options
May 26, 2016 at 11:48 AM EDT
Investors eyeing a purchase of Celldex Therapeutics, Inc. (CLDX) shares, but tentative about paying the going market price of $4.21/share, might benefit from considering selling puts among the alternative strategies at their disposal..